Taddese Desta

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Douglas K. Rex, Raj Bhandari, Taddese Desta et al. · Gastrointestinal Endoscopy · 2018 · 296 citations · Full text

Patient Safety, Gastroenterology, Pharmacotherapy +5

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 131 citations · Full text

Difference Between Latiglutenase, Villous Atrophy, Clinical Presentation +3

EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

Vlad Ratziu, Mary E. Rinella, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology · 2021 · 107 citations

Clinical Endpoint, Clinical Trials, Treatment Option +2

Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents?

Joseph W. Leung, Yan Lei Liu, Taddese Desta et al. · Gastrointestinal Endoscopy · 1998 · 67 citations

Synergistic Effect, Mixed Bacterial Infection, Antimicrobial Susceptibility +9

In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage

Joseph W. Leung, Yanlei Liu, Taddese Desta et al. · Gastrointestinal Endoscopy · 2000 · 42 citations

Antibiotic Prophylaxis, Antimicrobial Susceptibility, Antibiotics +9